Detection and validated quantification of 21 benzodiazepines and 3 "z-drugs" in human hair by LC-MS/MS

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 64-72

  Rust, Kristina Y ^a   Baumgartner, Markus R ^a   Meggiolaro, Natascha ^a   Kraemer, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Abstinence control; Benzodiazepines; Driving under the influence; Hair analysis; LC MS MS; Z drugs

Indexed keywords

7 AMINOCLONAZEPAM; 7 AMINOFLUNITRAZEPAM; ALPHA HYDROXYMIDAZOLAM; ALPRAZOLAM; AMMONIUM FORMATE; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BUFFER; CHLORDIAZEPOXIDE; CLONAZEPAM; DEALKYLFLURAZEPAM; DIAZEPAM; DRUG; FLUNITRAZEPAM; FLURAZEPAM; LORAZEPAM; LORMETAZEPAM; METHANOL; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; PHENAZEPAM; PRAZEPAM; TEMAZEPAM; TRIAZOLAM; UNCLASSIFIED DRUG; WATER; Z DRUG; ZALEPLON;

ANALYTICAL PARAMETERS; ARTICLE; COLUMN CHROMATOGRAPHY; DRUG DETERMINATION; DRUG HAIR LEVEL; ELECTROSPRAY MASS SPECTROMETRY; ENHANCED PRODUCT ION SCAN; FLOW; HAIR ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFORMATION DEPENDENT ACQUISITION; MONITORING; MULTIPLE REACTION MONITORING; PH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; VALIDITY;

EID: 84856425446     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.07.052     Document Type: Article

References (31)

1. Kraemer T., Maurer H.H. Forensic toxicology: sedatives and hypnotics. Handbook of Analytical Separation Sciences: Forensic Sciences 2007, 247. Elsevier Science, Amsterdam. 2nd ed. M. Bogusz (Ed.).
2. Askew J.P. Zolpidem addiction in a pregnant woman with a history of second-trimester bleeding. Pharmacotherapy 2007, 27:306-308.
3. Benyamina A., Dublanchet O., Karila L., Blecha L., Reynaud M. Intravenous zolpidem abuse: a case for serotonin depletion. Am. J. Addict. 2007, 16:534.
4. Cimolai N. Zopiclone: is it a pharmacologic agent for abuse?. Can. Fam. Physician 2007, 53:2124-2129.
5. Cubala W.J., Landowski J. Seizure following sudden zolpidem withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:539-540.
6. Cubala W.J., Landowski J., Wichowicz H.M. Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects. Br. J. Clin. Pharmacol. 2008, 65:444-445.
7. Jaffe J.H., Bloor R., Crome I., Carr M., Alam F., Simmons A., Meyer R.E. A postmarketing study of relative abuse liability of hypnotic sedative drugs. Addiction 2004, 99:165-173.
8. Licata S.C., Penetar D.M., Dunlap S., Lukas S.E. A therapeutic dose of zolpidem has limited abuse-like effects in drug-naive females: a pilot study. Eur. J. Pharmacol. 2008, 598:64-67.
9. Paparrigopoulos T., Tzavellas E., Karaiskos D., Liappas I. Intranasal zaleplon abuse. Am. J. Psychiatry 2008, 165:1489-1490.
10. Gustavsen I., Al-Sammurraie M., Morland J., Bramness J.G. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid. Anal. Prev. 2009, 41:462-466.
11. Karjalainen K., Lintonen T., Impinen A., Makela P., Rahkonen O., Lillsunde P., Ostamo A. Mortality and causes of death among drugged drivers. J. Epidemiol. Community Health 2010, 64:506-512.
12. Rapoport M.J., Lanctot K.L., Streiner D.L., Bedard M., Vingilis E., Murray B., Schaffer A., Shulman K.I., Herrmann N. Benzodiazepine use and driving: a meta-analysis. J. Clin. Psychiatry 2009, 70:663-673.
13. Senna M.C., Augsburger M., Aebi B., Briellmann T.A., Donze N., Dubugnon J.L., Iten P.X., Staub C., Sturm W., Sutter K. First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci. Int. 2010, 198:11-16.
14. Smink B.E., Egberts A.C., Lusthof K.J., Uges D.R., de Gier J.J. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs 2010, 24:639-653.
15. Kronstrand R., Nystrom I., Forsman M., Kall K. Hair analysis for drugs in driver's license regranting. A Swedish pilot study. Forensic Sci. Int. 2010, 196:55-58.
16. Mieczkowski T. Urinalysis and hair analysis for illicit drugs of driver applicants and drivers in the trucking industry. J. Forensic Leg. Med. 2010, 17:254-260.
17. Pragst F., Balikova M.A. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta 2006, 370:17-49.
18. Kintz P. Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes [review]. Anal. Bioanal. Chem. 2007, 388:1467-1474.
19. Kintz P., Villain M., Cirimele V. Chemical abuse in the elderly: evidence from hair analysis. Ther. Drug Monit. 2008, 30:207-211.
20. Madea B., Musshoff F. Knock-out drugs: their prevalence, modes of action, and means of detection. Dtsch. Arztebl. Int. 2009, 106:341-347.
21. Scott K.S. The use of hair as a toxicological tool in DFC casework. Sci. Justice 2009, 49:250-253.
22. Xiang P., Sun Q., Shen B., Chen P., Liu W., Shen M. Segmental hair analysis using liquid chromatography-tandem mass spectrometry after a single dose of benzodiazepines. Forensic Sci. Int. 2010, 204:19-26.
23. Peters F.T., Drummer O.H., Musshoff F. Validation of new methods. Forensic Sci. Int. 2007, 165:216-224.
24. Peters F.T. Method validation using LC-MS. Applications of Liquid Chromatography-Mass Spectrometry in Toxicology 2006, 71. Pharmaceutical Press, London. A. Polettini (Ed.).
25. European Communities COMMISSION DECISION of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Communities 2002, L221:8-36.
26. Fox E.J., Twigger S., Allen K.R. Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice. Ann. Clin. Biochem. 2009, 46:50-57.
27. Schurmann A., Dvorak V., Cruzer C., Butcher P., Kaufmann A. False-positive liquid chromatography/tandem mass spectrometric confirmation of sebuthylazine residues using the identification points system according to EU directive 2002/657/EC due to a biogenic insecticide in tarragon. Rapid Commun. Mass Spectrom. 2009, 23:1196-1200.
28. Beyer J., Peters F.T., Kraemer T., Maurer H.H. Detection and validated quantification of toxic alkaloids in human bllod plasma-comparison of LC-APCI-MS with LC-ESI-MS/MS. J. Mass Spectrom. 2007, 42:621-633.
29. Beyer J., Peters F.T., Kraemer T., Maurer H.H. Detection and validated quantification of herbal phenalkylamines and methcathinone in human blood plasma by LC/MS/MS. J. Mass Spectrom. 2007, 42:150-160.
30. Roy A.N., Smith M. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med. 2010, 11:462-469.
31. Bachmann C.S., Berg E.A., Spigset O., Slordal L. Benzodiazepine-like hypnotics-attitudes and prescription practice among general practitioners. Tidsskr. Nor. Laegeforen. 2008, 128:166-170.